The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
@B. Thanks for reporting back. Seems a decent, clear response. Perhaps we can now cross off “lack of responsiveness” from his list of failings!?
Seems a good number that we are getting some of our money back from doing work on the licence - every penny counts.
Still all of no use if they can’t farm it out - and soon. We need a significant event to break free of whoever is selling off whenever anyone dares to buy a few more.
@B. I would be disappointed if that was so and it wasn’t going back to eog -as I noticed that Antler were paying eog for any work they did on processing the data etc. May be worth giving them more than a couple of days to respond before making that assumption?
Think WH is pretty good at responding. Only address I have is the standard one mail@europaoil.com - maybe Itsawrap has a better one as I think he asked a question on flowrates today and got an answer pretty much at once.
@Biggleswerf. As I understand it he’s a Director of Antler as the EOG representative, not as a private individual - so very much doubt he gets a separate salary for this. But you could always ask eog directly - I am sure they will tell you - and if they won’t that would probably answer your question as well!
An explanation from Corporate Governance Rules as WH said (whether we like it or not)
“The board should be of an appropriate size. At least half the members of the board, excluding the chairman, should be independent non-executive directors. To ensure that power and information are not concentrated in one or two individuals, there should also be a strong executive representation on the board.”
What I find frustrating is we seem to be talking more about internal admin arrangements than progress made on assets - which should be the main focus at this time.
@Flombo let’s hope so on Ireland. Also I haven’t seen anything yet to suggest that EQ won’t pay off - as Aimshame flagged up earlier others are taking up licences in the area, so the interest is clear. As for Wressle - I think some were on UJO last week predicting dire results for January’s flowrates until they turned out fine on the NSTA results that Itsawrap provided for us. So I am happy to wait and see how accurate GC predictions are - Wressle has usually surprised to the upside so far.
@itsawrap. Interims are out later this month so we should see then how much free cash has been generated and get a forecast perhaps covering recent months since Wressle has started to flow again. If Wressle is back consistently above 600bopd it seems likely that at current OP of over $90 it should be healthy enough to fund development of all current projects and give us some spare - so let’s get on with it.
So Whisby looks the best of the bunch - on an average of 32bopd about 21bopd to EOG.
That makes the total production from assets other than Wressle about 38bopd. That’s a fair bit higher than I thought and at current OP still worth having in the background.
Thanks for all your research Itsawrap.